EssilorLuxottica Société anonyme against Eli Lilly and Company — live side-by-side technical comparison.
Prices as of 2026-09-23T15:36:14+00:00 UTC · updates daily
EL.PA leads 3 of the 5 windows we measure — over 1 month EL.PA is -7.3% and LLY -7.7%; over year to date EL.PA is -44.4% and LLY +7.1%.
| EL.PA | LLY | |
|---|---|---|
| Price | $149.95 | $1150.99 |
| 1 day | +3.8%lead | -1.6% |
| 5 days | +3.3%lead | +1.2% |
| 1 month | -7.3%lead | -7.7% |
| 6 months | -22.3% | +26.4%lead |
| Year to date | -44.4% | +7.1%lead |
| 52-week position | 6% of range | 76% of range |
| 52-week range | $138.30–$323.80 | $712.05–$1292.65 |
| vs 50-day average | below $159.21 | below $1176.62 |
| vs 200-day average | below $199.87 | above $1068.31 |
| RSI (14) | 45 | 46 |
| Next earnings | 2026-02-11 | 2026-10-29 |
EL.PA trades at $149.95, below its 50-day average of $159.21, and below the 200-day at $199.87. It sits at 6% of its 52-week range ($138.30–$323.80); 14-day RSI is 45, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $150.00 (0.0% away) and the first support below is $139.00 (7.3% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
LLY trades at $1,150.99, below its 50-day average of $1,176.62, and above the 200-day at $1,068.31. It sits at 76% of its 52-week range ($712.05–$1,292.65); 14-day RSI is 46, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $1,176.62 (2.2% away) and the first support below is $1,150.00 (0.1% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
EL.PA is the more volatile of the two — an average session moves it 2.6% against 2.4% for LLY, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; LLY clearing $1,176.62 or losing $1,150.00. Until one of them gives way, the relative reading above stands.